NYSE Strategist Eric Criscuolo shares his take on the markets and biotech sentiment

He discusses the importance of interest rates to high risk sectors like biotech, and comment on how our sector has not performed lately like other "risk-on" assets have. Plus, explaining his job of helping CEOs of NYSE listed companies understand the economic and capital markets environment.

Note: The NYSE is a sponsor of BiotechTV